No abstract available
MeSH terms
-
Acquired Hyperostosis Syndrome / drug therapy
-
Adolescent
-
Adult
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use*
-
Antirheumatic Agents / administration & dosage
-
Antirheumatic Agents / therapeutic use*
-
Arthritis, Juvenile / drug therapy*
-
Arthritis, Psoriatic / drug therapy*
-
Behcet Syndrome / drug therapy
-
Child
-
Child, Preschool
-
Clinical Trials as Topic
-
Etanercept
-
Female
-
Humans
-
Immunoglobulin G / administration & dosage
-
Immunoglobulin G / therapeutic use*
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / therapeutic use*
-
Infliximab
-
Male
-
Multicenter Studies as Topic
-
Placebos
-
Receptors, Tumor Necrosis Factor / administration & dosage
-
Receptors, Tumor Necrosis Factor / therapeutic use*
-
Sarcoidosis / drug therapy
-
Sjogren's Syndrome / drug therapy
-
Spondylitis, Ankylosing / drug therapy*
-
Time Factors
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Vasculitis / drug therapy
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Immunoglobulin G
-
Immunosuppressive Agents
-
Placebos
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Etanercept